Alessandra Lugo1, Giulia Peveri2, Cristina Bosetti3, Vincenzo Bagnardi4, Alessio Crippa5, Nicola Orsini6, Matteo Rota7, Silvano Gallus8. 1. Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. 2. Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy; Department of Molecular and Translational Medicine, Università degli Studi di Brescia, Brescia, Italy. 3. Department of Oncology, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. 4. Department of Statistics and Quantitative Methods, Università Degli Studi di Milano-Bicocca, Milan, Italy. 5. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 6. Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden. 7. Department of Clinical Sciences and Community Health, Università Degli Studi di Milano, Milan, Italy. 8. Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy. Electronic address: silvano.gallus@marionegri.it.
Abstract
AIM: Cigarette smoking is an established risk factor for pancreatic cancer but an updated quantification of the association is lacking. Our aim is to provide the most accurate and updated estimate of the dose-response relationships between cigarette smoking and pancreatic cancer risk. METHODS: Using an innovative approach for the identification of original publications, we conducted a systematic review and meta-analysis of epidemiological studies published on the issue up to April 2017. Random effects models were used to provide pooled estimates for the cigarette smoking status; dose-risk relationships were evaluated using one-stage random effects models with restricted cubic splines. RESULTS: Seventy-eight studies were included, providing a pooled relative risk (RR) of pancreatic cancer of 1.8 (95% confidence interval, CI: 1.7-1.9) for the current and 1.2 (95% CI: 1.1-1.2) for the former vs. never smokers. A sharp increase in pancreatic cancer risk was found already with a low number of cigarettes and up to 30 cigarettes/day (RR 2.2, 95% CI: 1.9-2.4). Similarly, the risk of pancreatic cancer steady increased after a few years of smoking up to 30 years (RR 1.8, 95% CI: 1.6-2.0). The risk rapidly decreased with increasing time since quitting and was 0.6 (95% CI: 0.5-0.7, for the former vs. current smokers) after 20 years of quitting. CONCLUSIONS: The present meta-analysis indicates that pancreatic cancer risk sharply increases with a low number of cigarettes or after a few years of smoking and that it rapidly decreases a few years after cessation, although it takes almost 20 years to reach that of never smokers.
AIM: Cigarette smoking is an established risk factor for pancreatic cancer but an updated quantification of the association is lacking. Our aim is to provide the most accurate and updated estimate of the dose-response relationships between cigarette smoking and pancreatic cancer risk. METHODS: Using an innovative approach for the identification of original publications, we conducted a systematic review and meta-analysis of epidemiological studies published on the issue up to April 2017. Random effects models were used to provide pooled estimates for the cigarette smoking status; dose-risk relationships were evaluated using one-stage random effects models with restricted cubic splines. RESULTS: Seventy-eight studies were included, providing a pooled relative risk (RR) of pancreatic cancer of 1.8 (95% confidence interval, CI: 1.7-1.9) for the current and 1.2 (95% CI: 1.1-1.2) for the former vs. never smokers. A sharp increase in pancreatic cancer risk was found already with a low number of cigarettes and up to 30 cigarettes/day (RR 2.2, 95% CI: 1.9-2.4). Similarly, the risk of pancreatic cancer steady increased after a few years of smoking up to 30 years (RR 1.8, 95% CI: 1.6-2.0). The risk rapidly decreased with increasing time since quitting and was 0.6 (95% CI: 0.5-0.7, for the former vs. current smokers) after 20 years of quitting. CONCLUSIONS: The present meta-analysis indicates that pancreatic cancer risk sharply increases with a low number of cigarettes or after a few years of smoking and that it rapidly decreases a few years after cessation, although it takes almost 20 years to reach that of never smokers.
Authors: Inger T Gram; Song-Yi Park; Lynne R Wilkens; Loïc Le Marchand; Veronica Wendy Setiawan Journal: Cancer Causes Control Date: 2022-10-17 Impact factor: 2.532
Authors: Shervin Assari; James Smith; Ritesh Mistry; Mehdi Farokhnia; Mohsen Bazargan Journal: Int J Environ Res Public Health Date: 2019-05-23 Impact factor: 3.390
Authors: Shervin Assari; James L Smith; Marc A Zimmerman; Mohsen Bazargan Journal: Int J Environ Res Public Health Date: 2019-04-04 Impact factor: 3.390
Authors: Mohsen Bazargan; James L Smith; Paul Robinson; John Uyanne; Ruqayyah Abdulrahoof; Chika Chuku; Shervin Assari Journal: Int J Environ Res Public Health Date: 2019-05-17 Impact factor: 3.390
Authors: Maria A Stevens; Kari G Rabe; Ben Boursi; Aarti Kolluri; Dhruv P Singh; William R Bamlet; Gloria M Petersen Journal: Mayo Clin Proc Innov Qual Outcomes Date: 2020-12-10
Authors: Ciro Conversano; Mariagrazia Di Giuseppe; Mario Miccoli; Rebecca Ciacchini; Annarita Di Silvestre; Rosa Lo Sterzo; Angelo Gemignani; Graziella Orrù Journal: Clin Neuropsychiatry Date: 2020-08